MedPath

Treatment of Dysphagia Using the Mendelsohn Maneuver

Phase 1
Completed
Conditions
Dysphagia
Stroke
Interventions
Behavioral: Mendelsohn Maneuver
Registration Number
NCT00592761
Lead Sponsor
University of Arkansas
Brief Summary

The primary goal of the investigation is to determine the effects of the Mendelsohn maneuver on the physiology of the swallow in individuals who have suffered a stroke and exhibit signs of pharyngeal dysphagia.

Detailed Description

The primary goal of the investigation is to determine the effects of the Mendelsohn maneuver (voluntary prolongation of laryngeal excursion at the midpoint of the swallow) on the physiology of the swallow in individuals who have suffered a stroke and exhibit signs of pharyngeal dysphagia (specifically, reduced duration of hyoid maximum elevation, reduced extent of hyoid maximum elevation, reduced duration of hyoid maximum anterior excursion, reduced extent of hyoid maximum anterior excursion, and reduced duration of upper esophageal sphincter (UES) opening with subsequent residue in the pyriform sinuses and, potentially, aspiration). Participants are assessed with videofluoroscopy at the initiation of the study and after each week of the study. After the 4 weeks of participation are complete, all participants will be discharged from treatment and will be brought back to the clinic for a final Videofluoroscopic Swallow Study (VFSS) evaluation after 2 weeks. This means that individuals in Group 1 will be re-analyzed after 1 month of additional no-treatment, and Group 2 will be re-analyzed after 2 additional weeks of no-treatment.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
18
Inclusion Criteria
  • Stroke (1-18 months post)
  • Pharyngeal Dysphagia
Exclusion Criteria
  • Other neurologic or structural abnormality to oropharynx
  • History of dysphagia prior to latest stroke

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Within subjects treatment, no-treatmentMendelsohn ManeuverWithin subject, treatment and no-treatment periods. Each participant served as his/her own control in this AABB/BBAA alternating treatment conditions design. Results were also compared across groups (treatment v. no-treatment).
Primary Outcome Measures
NameTimeMethod
Change in Duration of Superior Hyolaryngeal Movementbaseline and six weeks

Change in duration of superior elevation of hyoid bone.

Change in Duration of Hyoid Maximum Anterior ExcursionBaseline and 6 weeks

Change in the duration of maximum anterior movement of the hyoid bone during swallowing.

Secondary Outcome Measures
NameTimeMethod
Change in Oral Intake AbilityBaseline and 6 weeks

Oral Intake Ability was measure with the Dysphagia Outcome and Severity Scale. A 7 is normal and a 1 is complete inability to consume any food safely. The means reported for treatment and no treatment periods are mean changes in scores throughout the period.

Change in Duration of Opening of Upper Esophageal SphincterBaseline and 6 weeks

Change in duration of pre- and post-treatment duration of UES opening.

Trial Locations

Locations (1)

UArkansas/UAMS Medical Center

🇺🇸

Little Rock, Arkansas, United States

© Copyright 2025. All Rights Reserved by MedPath